Overview

Ointment Therapy and Prevention of Cannulation-Induced Superficial Phlebitis

Status:
Not yet recruiting

Trial end date:
2021-05-01

Target enrollment:
0

Participant gender:
All

Summary

The aim of this study was to determine the effect of Clobetasol ointment with nitroglycerin ointment on the prevention of superficial phlebitis caused by cannulation. This clinical trial was conducted on 110 patients admitted to the surgical ward, in three groups of Clobetasol, nitroglycerin, and control. The data collection tools included demographic information, information about intravenous treatment and phlebitis measurement scale. In the intervention groups, after venipuncture, 1.5 cm (about 2 g) of ointment was applied in the distal part of the Angio catheter and the site was dressed with sterile gauze. In three time periods of 24, 48 and 72 hours from the time of venipuncture.

Phase:

Phase 1/Phase 2

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Komar University of Science and Technology

Treatments:

Clobetasol
Nitroglycerin

Criteria

Inclusion Criteria:

- must be older than 18 years old

- must be in need of hospitalization at least 72 hours

- does not state any previous allergic reaction to the ointments

- does not use any types of drug that can hurts veins (chemotherapy drugs, diazepam.
amiodarone, and....)

Exclusion Criteria:

- active infection

- discharge from hospital sooner than 72 hours

- displacement of cannula before 72 hours